Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Operating Leases (2019 - 2025)

CV Sciences' Operating Leases history spans 7 years, with the latest figure at $100000.0 for Q4 2025.

  • On a quarterly basis, Operating Leases rose 426.32% to $100000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 426.32% increase, with the full-year FY2025 number at $100000.0, up 426.32% from a year prior.
  • Operating Leases hit $100000.0 in Q4 2025 for CV Sciences, down from $162000.0 in the prior quarter.
  • Over the last five years, Operating Leases for CVSI hit a ceiling of $3.3 million in Q1 2021 and a floor of $19000.0 in Q4 2024.
  • Historically, Operating Leases has averaged $548000.0 across 5 years, with a median of $203500.0 in 2022.
  • Biggest five-year swings in Operating Leases: crashed 91.7% in 2024 and later skyrocketed 426.32% in 2025.
  • Tracing CVSI's Operating Leases over 5 years: stood at $3.1 million in 2021, then tumbled by 93.96% to $188000.0 in 2022, then tumbled by 69.15% to $58000.0 in 2023, then plummeted by 67.24% to $19000.0 in 2024, then skyrocketed by 426.32% to $100000.0 in 2025.
  • Business Quant data shows Operating Leases for CVSI at $100000.0 in Q4 2025, $162000.0 in Q3 2025, and $230000.0 in Q2 2025.